The European Commission’s DG Research and Innovation considers DEEP project as an excellent example of fruitful project, working on the integration of the existing information on deferiprone use in paediatric patients, and providing a valid support to the use of the drug in this class of age.
The DEEP (DEferiprone Evaluation in Paediatrics) Project Open Meeting was held in Tirana at the Hotel Tirana International on May 18, 2015. DEEP was a 4-year European research project (FP7) coordinated by CVBF. It included 28 recruitment sites located in 5 European...
The fourth issue of the newsletter pertaining to DEEP-2 clinical trial, one of the three studies at the bottom of the DEEP Project (DEferiprone Evaluation in Paediatrics) was published on January 7th, 2015. This Newsletter highlights the main progresses achieved in...
Representatives from all the DEEP Consortia gathered together in the Project General Assembly and Scientific Meeting that took place in Athens on July 3rd-5th2014. This event confirmed the positive outcomes of the DEEP project, that will grant soon paediatric patients...
“DEEP is a success story because DEEP is a special project”, underlined DEEP Scientific Coordinator and member of the PDCO-EMA Adriana Ceci at the regional conference “Meeting EuroMed Common Challenges”, organised in Cairo by the European Commission to launch Horizon...
The European Project DEEP, DEferiprone Evaluation in Paediatrics, was presented in Bari at the Sheraton Nicolaus Hotel at 2 PM. This presentation occurred during the opening session of the Kick-off Meeting (KoM), which lasted until April 16th. The KoM was organized by...
Recent posts in DEEP, Updates from projects